Quick Job Search
Enter Keyword(s):
Enter a City:  

Select a State:

Select a Category:


  - Advanced Job Search
  - Search by Category

Biotech News

 
I Ditched My Career - Sponsored Link
Report exploring attitudes to GM food published
Ardea Biosciences to Present at the Piper Jaffray 21st Annual
Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
BEFORE THE BELL-Incyte jumps on Novartis licensing deal
Sinovac Biotech Executes JV Deal To Establish Sinovac Vaccine Technology Co. - Quick Facts
Medical News: Genome-wide Association Studies In Developing Countries Raise Important New Ethical Issues
Medical News: Genome-wide Association Studies In Developing Countries Raise Important New Ethical Issues
Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN
People want independent information on GM foods, finds new study
Incyte and Novartis form licensing agreement for two haematology-oncology programmes
Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN
Identifying repeats and transposable elements in sequenced genomes: how to find your way through the dense forest of programs
Effect of IFN-beta therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary study
EMEA grants orphan drug status for LFB Biotechnologies' recombinant anti-CD20 monoclonal antibody
Ambit Biosciences presents data evaluating FLT3 inhibitor in AML at the 51st ASH meeting
Incyte Announces Major Collaboration and License Agreement for Two Hematology-Oncology Programs
LFB Biotechnologies announces orphan drug status in Europe for anti-CD20 monoclonal antibody
Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS
Human Genome Sciences (HGSI) Submits BLA to U.S. FDA for Hep C Treatment ZALBIN
Incyte (INCY) Enters Investigational Hermatology-Oncology Collaboration Agreement with Novartis (NVS)
Genome-wide SNP analysis reveals no gain in power for association studies of common variants in the Finnish Saami
Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases
Genome scan for loci regulating HDL cholesterol levels in Finnish extended pedigrees with early coronary heart disease
A data-driven weighting scheme for family-based genome-wide association studies
Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN
Novartis Moves for Incyte's Cancer Therapies
Affymetrix to Webcast Presentation at the 23rd NASDAQ OMX Investor Forum
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
Incyte and Novartis form licensing agreement for two haematology-oncology programmes
Merck Serono to Spend $225 Million on New Beijing R&D Center